b'20. Takes note with appreciation of the Mministerial Ddecision on the TRIPS Agreement that was agreed to at the twelfth Ministerial Conference of the World Trade Organization to authorize the use of the subject matter of a patent required for the production and supply of COVID-19 vaccines without the consent of the right holder to the extent necessary to address the COVID-19 pandemic, in accordance with the provisions of Aarticle 31 of the TRIPS Agreement, as clarified and waived in the Ministerial Decision, and notes thaturges members of the World Trade Organization is currently deliberatingto expeditiously decide on the extension of the Mministerial Ddecision to cover the production and supply of COVID-19 diagnostics and therapeutics; '